Newly Diagnosed Medulloblastoma clinical trials

Explore recruiting newly diagnosed medulloblastoma clinical trials.

Recruiting newly diagnosed medulloblastoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Newly Diagnosed Medulloblastoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EORTC 1634-BTG (NOA-23): Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly Diagnosed Medulloblastoma (PersoMed-I)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Newly Diagnosed Medulloblastoma trials by city

Newly Diagnosed Medulloblastoma in Toronto Newly Diagnosed Medulloblastoma in Vancouver Newly Diagnosed Medulloblastoma in Montreal Newly Diagnosed Medulloblastoma in Calgary Newly Diagnosed Medulloblastoma in Edmonton Newly Diagnosed Medulloblastoma in Ottawa Newly Diagnosed Medulloblastoma in Winnipeg Newly Diagnosed Medulloblastoma in Quebec City Newly Diagnosed Medulloblastoma in Hamilton Newly Diagnosed Medulloblastoma in Kitchener Newly Diagnosed Medulloblastoma in London Newly Diagnosed Medulloblastoma in Halifax Newly Diagnosed Medulloblastoma in New York Newly Diagnosed Medulloblastoma in Los Angeles Newly Diagnosed Medulloblastoma in Chicago Newly Diagnosed Medulloblastoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease